Recently, the 11th 36Kr Wise2023 King of Business Conference was grandly held at the Beijing International Convention Center. During the conference, the selection list of WISE Business King 2023 Potential Innovation Company was announced at the same time, and Yuyue Medical won the "WISE Business King 2023 Potential Innovation Company" award by virtue of its technological innovation advantages and brand accumulation in the field of medical devices for more than 20 years.
With the theme of "The Sun Also Rises", the WISE2023 King of Business Conference brings together leaders from all business fields to think together, expand, transfer and cooperate, find internal motivation, stimulate innovative thinking and action, and explore opportunities for innovation and breakthroughs in the changing situation.
Since the beginning of 2023, the post-pandemic economic recovery momentum has been weak, and China's economy is facing a more complex macro environment. But truly resilient and innovative companies are not afraid of the ebb and flow of the tide, and even show unprecedented potential.
For Yuyue Medical, insisting on quality and innovative technology has long become the company's development gene, and the company achieved operating income of 66 in the first three quarters of this year6.3 billion yuan, R&D expenses 39.7 billion yuan, an increase of 416%。Strong product innovation and technical strength drive Yuyue Medical-related products to lead the market. Taking the core product oxygen concentrator as an example, Yuyue Medical has carried out more than 1,000 technological innovations, obtained a number of national patents, and was recognized as a single champion product in the list of the fourth batch and the first batch of manufacturing individual champions to be reviewed announced by the Ministry of Industry and Information Technology.
In addition, this year, Yuyue Medical's multi-business lines have launched blockbuster innovative products, and in the field of blood glucose monitoring, Yuyue Medical's new generation of Annai Sugar AnytimeCT3 CT15 can be calibrated for 14 days has been successfully launched to the market. In the field of first aid, the first batch of localized Y series AEDs rolled off the production line, marking the arrival of the era of domestic autonomy of AED. According to market analysts, with the coordinated advancement of production, R&D and operation, Yuyue Medical is expected to achieve a rapid breakthrough in the process of popularizing the new infrastructure of AED medical care.
Up to now, Yuyue Medical's products cover more than 600 categories and nearly 10,000 specifications such as electronic sphygmomanometers, blood glucose meters, ventilators, oxygen concentrators, body temperature monitoring, and first-class equipment, which can meet the needs of various equipment in family medical scenarios, and the company has established 12 R&D centers and 9 manufacturing centers in Shanghai, Nanjing, Germany, Italy and other places, forming a complete global R&D, production, marketing and service network, covering 131 overseas countries and regions.
Risk Warning: The information on this platform is not used as the basis for investment decision-making, and you are at your own risk.